Skip to content


Chronic kidney disease and hypertension

What did we do?

This work was to spread the CKD IMPAKT™ work (developed during the previous CLAHRCs round of funding) NHS Central Manchester CCG (now Manchester CCG) and NHS Bury CCG. The aim of this work was to increase the knowledge of healthcare professionals and improve the quality of services and care provided to Chronic kidney disease (CKD) patients.


‘Click here for more information about what work we’ve done on CKD in the past’


Why was it important?

Excess cardiovascular disease related to CKD is thought to cost the NHS in England £175 million each year. With end stage CKD growing at an estimated 6% per annum, diagnosing and treating CKD effectively as early as possible is hugely important. The project aimed to result in:


  • Primary care clinicians being more confident in the Read coding and management of CKD.

  • An increase in CKD diagnoses (finding patients with CKD who do not currently have a diagnosis).

  • Improvements in the management of CKD patients.

  • Primary care staff being more confident in the use of quality improvement methods which can be transferred to other projects/activity.

  • An increased spread and sustainability of the IMPAKT™ tool.


How did we do it?

We focussed on reducing the gap between the recorded and estimated prevalence of CKD on practice registers. We also worked towards a higher rate of CKD patients being tested for proteinuria and managed to National Institute for Health and Care Excellence (NICE) recommended blood pressure targets.


Who did we work with?

NHS Central Manchester CCG



Downloadable resources


More information

For further information, please contact  Susan Howard (Programme Manager) or Tom Blakeman (Principle Investigator)